Awards Takeda 2012: Second Edition of the contest of clinical cases of patients with Osteoporosis.

“The world every 3 seconds someone suffers a fracture from osteoporosis”. International Osteoporosis Foundation (IOF).

-Takeda again convene in Spain the 2012 Takeda Awards, second edition of its competition of clinical cases of patients with osteoporosis. The pharmaceutical has once again in this initiative with the support and collaboration of the Spanish society of rehabilitation and physical medicine (SERMEF) and Postgraduate Institute for medicine and health (IPEM)

Madrid, may 2012.- Takeda, company that sells Preotact — only complete chain parathyroid hormonePTH (1-84) – launches the II contest of clinical cases of patients with Osteoporosis.

This competition aims to reward innovation, originality, rigor and scientific quality of the work submitted medical specialists in rehabilitation and physical medicine, relating to clinical cases of osteoporóticos patients at high risk of fracture and/or osteoporotic fracture.

For specialists, this contest was an opportunity to scientifically document their experience in their daily work with patients osteoporóticos, providing new information on the diagnosis and treatment of this disease.

As a novelty, this year the MIR may also submit their work, and can qualify for the award especially designed for them.

osteoporosis in figures

the International Osteoporosis Foundation ( IOF ) describes statistically what the epidemiological stage of this disease on a global scale and Spain.

According to the data handled by this organization in the world “every three seconds someone suffers a fracture from osteoporosis, and every 22 seconds a vertebral fracture”. Also, “women over 45 years old stay longer in the hospital from the osteoporosis than by any other disease, including diabetes, myocardial infarction and breast cancer”.

In Spain, approximately two million women have osteoporosis, with a prevalence of 26.1% in those that already reach age 50.

Each year occur 25,000 fractures, in economic terms implying State 126 million euros in direct costs and indirect 420 million.

In percentage of mortality, 13% of patients who have suffered a fracture die after three months and this figure increases to 38% after 24 months.

success of participation

the first edition of the contest of clinical cases of patients with Osteoporosis Nycomed obtained a important reception among medical specialists, with the presentation of numerous clinical cases; the pharmaceutical company subsequently published a selection of the best in a book which can be downloaded from the website of the competition www.rehabilitacionyosteoporosis.es .

The Scientific Committee, which will carry out an assessment blind clinical cases submitted to this second edition will be made by the following doctors:

-DRA. Mª Carmen García Ameijeiras, Vice President of the Spanish society of rehabilitation geriatric and a member of the Working Group for rehabilitation and Osteoporosis (GTRO) of the Spanish society for rehabilitation and physical medicine (SERMEF).

-Dr. Xoan Miguéns Vázquez, Secretary of the Working Group for rehabilitation and Osteoporosis (GTRO) of the society Spanish of rehabilitation and physical medicine (SERMEF) and coordinator of the Group of labour pain chronic in rehabilitation of the Spanish society of rehabilitation and physical medicine (SERMEF).

-Dr. Francisco Manuel Martín del Rosario. Spokesman for the winning group of specialists of the I Prize Nycomed. Physician specialist in physical medicine and rehabilitation of Hospital Universitario Insular of Gran Canaria
Secretary of the Working Group for rehabilitation Interventional for SERMEF.

The medical professionals in rehabilitation and physical medicine interested in participating may submit their work until May 9, 2012, sending them through the web page www.rehabilitacionyosteoporosis.es . Through this same site also will have access to all the information about the contest guidelines and editorial standards for the presentation of the papers.

what is Takeda Pharmaceutical Spain

Takeda Pharmaceutical Spain, S.A., headquartered in Madrid, is the Spanish subsidiary of marketing and sales of Takeda Pharmaceutical Company Limited.

As the largest pharmaceutical company in Japan and leader of the global industry, the Mission of Takeda focuses on improving the health of patients around the world leading medical innovation. As it has a commercial presence covering more than 70 countries, with special relevance in Asia, North America and Europe, and rapidly growing markets, among which are those of Latin America, Russia and the Confederation of independent countries (CIS) and China, Takeda occupies the place twelfth of global sales of products with prescription, the fourteenth in the BRIC countries (Brazil, Russia, India and China) and tenth eighth in Europe.

The commercial presence of Takeda mainly covers mainly the therapeutic areas of metabolic diseases, gastroenterological, oncological, cardiovascular, central nervous system, respiratory, immune and inflammatory, as well as the area of pain management.

For additional information about Takeda Pharmaceutical Spain, S.A., can consult their website www.nycomed.com/es/takeda/ .

What is SERMEF

SERMEF is a scientific society brings together more than 1,360 medical specialists in the field of rehabilitation whose work is to recover motor function. It is patients with acute or chronic pain, skeletal muscle diseases, as cervicalgia, back pain, scoliosis, tendonitis, fibromyalgia and neuralgias, as well as to people who have suffered severe traumatic injuries with multiple fractures or brain damage, and others who have suffered an episode of accident vascular brain with hemiplegia, and other neurological disorders (spinal cord injury)(, multiple sclerosis, sequelae of poliomyelitis, lateral sclerosis, Parkinson), (cifoscoliosis, malformations, amputations) orthopedic disorders or respiratory and heart diseases.

what is IPEM

the Institute of postgraduate studies medicine and health (IPEM) is the Division specialized in the health area of Editrain, a training company with over twenty years of experience, more than ten are linked to online training. With the aim of offering top quality training, Editrain, through IPEM Division, has signed collaboration agreements with some of the institutions, universities and most prestigious medical societies of Spain. These include agreements for the completion of postgraduate Masters with the universities of Alcalá, Complutense de Madrid and Universidad Castilla – La Mancha, Spain.